Table 1.
Demographic and medical characteristics of baseline sample (n = 50).
| Child’s/adolescent’s age at baseline (years), M ± SD (range) | 17.3 ± 2.1 years (13.1–22.6 years) |
|---|---|
| Type of diagnosis, n (%) | |
| Nephrology | 31 (62%) |
| Rheumatology | 7 (14%) |
| Hematology | 5 (10%) |
| Oncology | 7 (14%) |
| Duration of diagnosis (years), M ± SD (range) | 6.15 ± 5.0 |
| Child’s gender, n (%) | |
| Male | 21 (42%) |
| Female | 29 (58%) |
| Child’s ethnicity/race, n (%) | |
| Non-Hispanic, Caucasian | 17 (34%) |
| Non-Hispanic, minority | 30 (60%) |
| Hispanic | 3 (6%) |
| Scored measures (M ± SD) | |
| Resilience | 74.67 ± 13.95 |
| Transition readiness | 67.55 ± 8.20 |
| Medication adherence | 86.27% ± 15.98 |
| Medication adherence ratio (pharmacy refill) | 0.84 ± 0.23 |